A US hospital-data study published in 2024 associated recorded cannabis use with lower rates of severe complications and death among patients hospitalised with COVID-19. It does not prove cannabis prevents or treats COVID-19. Our overview of cannabis and respiratory health risks discusses smoking during viral illness. This was a retrospective observational analysis, rather than an experiment treating people with cannabis.
What did researchers examine?

Northwell Health researchers analysed records for 322,214 adult COVID-19 hospital patients in the US National Inpatient Sample. Cannabis use was recorded for 2,603 patients. Researchers compared those with and without this marker, including adjusted analyses intended to reduce differences in age and other characteristics.
Patients with recorded cannabis use had lower rates of severe COVID-19 complications, mechanical ventilation and death. Unadjusted figures showed severe illness in 28.2% versus 46.6%, and mortality of 2.8% versus 5.1%. These percentages must not be interpreted as proven protection from cannabis.
Why is this not a treatment recommendation?
Hospital records do not reliably establish route, dose, frequency or cannabinoid content. Some people who use cannabis may lack a corresponding record. Cannabis users were younger in the original sample and more often used tobacco. Statistical adjustment can reduce differences but cannot exclude every confounding factor.
The authors suggested cannabinoid effects on immune regulation as one possible explanation. This is a biological hypothesis, rather than a mechanism established by the study. Earlier laboratory findings about certain compounds and viral protein binding likewise do not show that cannabis prevents human infection.
What can be concluded?
The findings support further controlled clinical investigation of cannabinoids and inflammatory processes. They do not justify recommending cannabis smoking, use or increased doses to prevent or treat COVID-19. Inhaling smoke may be an additional problem during respiratory illness.
Original source: Wei and colleagues, “Exploring the Relationship Between Cannabis Use and COVID-19 Outcomes”, DOI 10.1089/can.2024.0048. Published online on 28 August 2024; the journal issue appeared in 2025.
Illustrative featured photograph: Edward Jenner / Pexels (Pexels License).